Innovative Leaders in Medical
Consolidation and Growth
Home | Contact Us
 
Home
Mission
Overview
Team
News
Contact
Home arrow News
 
Med Opportunity Partners, LLC makes strategic investment in Pfanstiehl, Inc.
April 1, 2013 - Med Opportunity Partners, LLC (“MEDOP”), a Greenwich CT-based private equity firm focused exclusively on the health care sector, announced today its acquisition of Ferro Pfanstiehl Laboratories, Inc., a global leader in cGMP carbohydrates and Active Pharmaceutical Ingredients (APIs), from Ferro Corporation. MEDOP, a strategic, operating-oriented investment firm, brings significant resources, pharmaceutical and biopharmaceutical relationships, and capital to fuel the Company’s growth.
Read more...
 
| © Med Opportunity Partners, LLC 2005 - 2011. All rights reserved. This is not a public solicitation. | design by beckercommunications |